Subsidy Progress Update

13 August 2018 

pixel pixel

Department of Health Update, posted on the Department’s website on 10 August 2018:

The Department of Health has undertaken an evaluation of the FreeStyle Libre product to consider its suitability for subsidisation through the NDSS.

This evaluation considered the clinical-effectiveness and cost-effectiveness of the product, and also included a public consultation process, which resulted in considerable feedback from people with diabetes, their families and other stakeholders.

Following completion of this process, the Department provided feedback to the sponsor on the results of the evaluation.  The sponsor has subsequently provided a revised submission which is being assessed by the Department through a similar process along with the feedback from the original public consultation.

Further information about the evaluation will be published on this website as it becomes available.

(the above update is current as of 10th August 2018, and available on


As evident from the Department’s update, the Department is assessing Abbott’s revised submission. The timeframe required for the completion of the assessment is governed by the Department of Health and the Federal Government is the ultimate decision maker. We do appreciate your patience and value your trust –we are doing all that is possible to assist in a timely decision.

Australia was one of the first countries to make FreeStyle Libre commercially available because of the great unmet need here to help people manage their glucose levels. We want to reassure you that it is our top priority to ensure equitable and affordable access to this revolutionary technology in Australia, at the earliest.

FreeStyle Libre system is now being used by more than 800,000 people around the world. There are 42 countries1 already using FreeStyle Libre, and 30 of these have FreeStyle Libre fully or partially reimbursed including the United Kingdom, France and Japan.

Our goal is to see Australia added to the list of the 30 countries where FreeStyle Libre is reimbursed, and are doing all that is possible to create a meaningful (and timely!) impact to the lives of Australians living with diabetes.

We will keep you updated on the latest information regarding the assessment, as it becomes available.

You are our inspiration!

The stories you have shared with us about how FreeStyle Libre has had an impact on your lives have been an absolute inspiration for us to keep working towards an NDSS subsidy.

Even as we do that, we continue to drive innovation – recently, we took another step forward in making glucose monitoring seamlessly fit into a user's daily lifestyle, with the launch of the FreeStyle LibreLink app for use with compatible smartphones (available free for download, on iOS and Android platforms2).

Users now have a choice to scan their FreeStyle Libre sensor using the FreeStyle Libre reader or their smartphone3.

We hope that this revolutionary technology creates a meaningful impact in the lives of many more Australians living with diabetes, helping them lead fuller, active and healthier lives. 


1 Data on file. Abbott Diabetes Care

2 The FreeStyle LibreLink app is compatible with NFC enabled phones running Android OS 5.0 or higher and with iPhone 7 and higher running OS 11 and higher.

3 The FreeStyle LibreLink app and the FreeStyle Libre reader have similar but not identical features. A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycaemia or impending hypoglycaemia is reported by the Sensor or when symptoms do not match the Sensor readings.